Abbott Laboratories Stock NEO Exchange
Stocks
ABT
CA0028221046
Medical Equipment, Supplies & Distribution
| Market Cap | 172B 150B 139B 128B 242B 16,588B 246B 1,660B 652B 8,100B 646B 632B 27,966B | P/E 2026 * |
26.1x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 195B 170B 157B 144B 273B 18,764B 278B 1,877B 737B 9,163B 731B 715B 31,634B | EV / Sales 2026 * |
3.87x | EV / Sales 2027 * | 3.4x |
| Free-Float |
86.73% | Yield 2026 * |
2.58% | Yield 2027 * | 2.75% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 172B | |
| -0.34% | +0.14% | -6.19% | -3.14% | 107B | |
| +1.35% | +3.06% | +6.23% | +62.76% | 59.92B | |
| +0.21% | +6.14% | -10.85% | -37.16% | 44.07B | |
| -1.12% | -0.83% | - | - | 34.76B | |
| -2.01% | +2.76% | -8.41% | -43.96% | 30.09B | |
| +0.60% | +2.19% | +63.13% | -5.77% | 25.61B | |
| -0.37% | +1.85% | -3.21% | -18.51% | 20.86B | |
| -0.81% | +1.92% | -1.98% | -3.59% | 21.55B | |
| +2.74% | +3.59% | -7.34% | +3.09% | 20.04B | |
| Average | +0.02% | +2.65% | +3.92% | -5.79% | 40.43B | |
| Weighted average by Cap. | -0.01% | +2.50% | +1.03% | -0.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.33B 44B 40.69B 37.34B 70.66B 4,850B 71.89B 485B 191B 2,368B 189B 185B 8,177B | 54.67B 47.78B 44.19B 40.55B 76.75B 5,268B 78.08B 527B 207B 2,572B 205B 201B 8,881B |
| Net income | 6.84B 5.97B 5.53B 5.07B 9.6B 659B 9.76B 65.89B 25.88B 322B 25.67B 25.1B 1,110B | 8.1B 7.08B 6.55B 6.01B 11.37B 780B 11.57B 78.06B 30.66B 381B 30.41B 29.74B 1,315B |
| Net Debt | 22.58B 19.74B 18.25B 16.75B 31.7B 2,176B 32.25B 218B 85.52B 1,063B 84.8B 82.94B 3,669B | 13.59B 11.88B 10.99B 10.08B 19.08B 1,309B 19.41B 131B 51.47B 639B 51.03B 49.91B 2,208B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
